← Open Payments lookup

NPI 1124197512: Open Payments

NPI 1124197512. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$597 in 16 payments from 14 companies in 2025. Trend: 2023 $406 · 2024 $790 · 2025 $597

Food & beverage: $498Education: $99
CompanyPaymentsAmount
Janssen Biotech, Inc.2$143
PFIZER INC.2$112
SEAGEN INC.1$99
EMD Serono, Inc.1$34
ABBVIE INC.1$26
Stemline Therapeutics Inc.1$25
Deciphera Pharmaceuticals Inc.1$24
Eisai Inc.1$24
ARRAY BIOPHARMA INC1$23
Gilead Sciences, Inc.1$22

Products named: RYBREVANT, XTANDI, ELAHERE, Orserdu, QINLOCK, Lenvima, LORBRENA, Trodelvy.